Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-26 Sale | 2024-08-28 4:15 pm | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. CHIEF LEGAL OFFICER | 35,713 | $2.6066 | $93,091 | 105,773 (Direct) | View |
| 2024-07-22 Sale | 2024-07-23 6:10 pm | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. CHIEF LEGAL OFFICER | 21,740 | $7.0597 | $153,477 | 141,486 (Direct) | View |
| 2023-11-14 Sale | 2023-11-16 4:32 pm | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 33,699 | $2.9437 | $99,200 | 123,226 (Direct) | View |
| 2023-07-24 Sale | 2023-07-25 4:25 pm | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 33,789 | $4.83 | $163,201 | 81,925 (Direct) | View |
| 2022-07-11 Purchase | 2022-07-11 5:24 pm | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 7,500 | $3.4 | $25,500 | 15,714 (Direct) | View |
| 2022-07-05 Purchase | 2022-07-05 4:13 pm | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 5,714 | $2.1 | $11,999 | 8,214 (Direct) | View |
| 2021-06-04 Purchase | 2021-06-07 08:42 am | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 2,500 | $9.79 | $24,475 | 2,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-09 Option Award | 2024-10-11 4:15 pm | N/A 2034-10-09 | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. CHIEF LEGAL OFFICER | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-19 4:31 pm | N/A 2034-03-15 | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. CHIEF LEGAL OFFICER | 120,000 | $0 | 243,226 (Direct) | View |
| 2023-08-24 Option Award | 2023-08-28 4:39 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 75,000 | $0 | 156,925 (Direct) | View |
| 2023-07-21 Option Award | 2023-07-25 4:25 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 100,000 | $0 | 81,925 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:25 pm | N/A 2033-02-28 | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-25 4:37 pm | N/A 2032-02-23 | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 5:01 pm | N/A 2031-02-28 | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 65,000 | $0 | 65,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 6:19 pm | N/A 2030-02-26 | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. General Counsel | 55,000 | $0 | 55,000 (Direct) | View |
Ownership | 2020-03-03 6:17 pm | N/A 2028-09-20 | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. General Counsel | 0 | $0 | 93,343 (Direct) | View |